ForumIAS announcing GS Foundation Program for UPSC CSE 2025-26 from 27th May. Click Here for more information.
What is the news?
Recently, World Health Organization (WHO) has granted Emergency Use Listing (EUL) to Covaxin. It took 20 weeks to approve the Covaxin after the data was supplied to WHO.
All about Covaxin
| Read here: covaxin vaccine |
What is the advantage of the approval?
1) Increase the global supply of vaccines. 2) Ease travel for Indians who are covaxin vaccinated.
What is the status of global vaccination?
WHO’s aims to vaccinate at least 40% of people in all countries by the year-end. But, According to British Medical Journal, the level of current vaccinations are very low.
Only around 1% of people in low-income countries have received their vaccine shot. 70 countries are yet to vaccinate 10% of their populations.
30 countries, including much of Africa, have vaccinated less than 2% of their population. In Latin America, only one in four of the population has received a vaccine dose.
Source: This post is based on the article “Keeping the faith: On WHO approval to Covaxin” published in The Hindu on 6th November 2021.
